TAp73α increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation(538 views) Malaguarnera R, Vella V, Pandini G, Sanfilippo M, Pezzino V, Vigneri R, Frasca F
Mol Cancer Res (ISSN: 1541-7786), 2008; 6(1): 64-77.
Keywords: Mutant Protein, Protein Mdm2, Protein P53, Protein Tap73alpha, Small Interfering Rna, Unclassified Drug, Article, Binding Site, Cancer Cell, Cancer Inhibition, Controlled Study, Dna Binding, Gene Deletion, Human, Human Cell, Priority Journal, Protein Binding, Protein Degradation, Protein Expression, Protein Function, Protein Protein Interaction, Protein Stability, Thyroid Cancer, Bcl-2-Associated X Protein, Competitive, Cell Line, Tumor, Cyclin-Dependent Kinase Inhibitor P21, Dna-Binding Proteins, Gene Expression Regulation, Neoplastic, Nuclear Proteins, Promoter Regions (genetics), Protein Processing, Post-Translational, Proto-Oncogene Proteins C-Mdm2, Thermodynamics, Thyroid Neoplasms, Transcription, Tumor Suppressor Protein P53,
Affiliations: *** IBB - CNR ***
Endocrinologia-Dipartimento di Medicina Interna e di Medicina Specialistica-Universita di Catania, Ospedale Garibaldi, Nesima, Italy
Serv. di Diabetologia-Dipto. di Medicina Interna e di Medicina Specialistica-Universita di Catania, Ospedale Cannizzaro, Catania, Italy
References: Not available.
TAp73α increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation